Latest News for: amorphous
Edit
Honeycomb-shaped micro-structures enhance thin film silicon solar cells
PV Magazine 23 Feb 2026
Edit
Citizen Tribune
17 Feb 2026
Amorphical to Present Long-Term Phase 2 Crohn's Disease Data at the 21st Congress of ECCO
Citizen Tribune
17 Feb 2026
Edit
Framework sets new benchmarks for 3D atom maps in amorphous materials
Phys Dot Org 28 Jan 2026
Researchers at the California NanoSystems Institute at UCLA published a step-by-step framework for determining the three-dimensional positions and elemental identities of atoms in amorphous materials.
Edit
LightPath Technologies Acquires Amorphous Materials, Inc (Form 8-K) (LightPath Technologies Inc)
Public Technologies 26 Jan 2026
Edit
Brattleboro Reformer
21 Jan 2026
LightPath Technologies Acquires Amorphous Materials, Inc.
Brattleboro Reformer
21 Jan 2026
Strategic Purchase to Add Proprietary Large Diameter Glass Melting Technology of Chalcogenide Glass ....
Edit
Citizen Tribune
16 Dec 2025
Amorphical Announces Positive Final Long-Term Results from Phase 2 Crohn's Disease Trial: Results Confirm Efficacy ...
Citizen Tribune
16 Dec 2025
Edit
Amorphical Announces Positive Final Long-Term Results from Phase 2 Crohn's Disease Trial: Results Confirm Efficacy and Show Sustained Clinical Remission
PR Newswire 16 Dec 2025
With more than a decade of real-world use of its nano-amorphous mineral therapeutics, Amorphical enters clinical development with valuable safety and tolerability insights to guide its regulatory pathway ... About Amorphical ... SOURCE Amorphical.
Edit
The Eagle-Tribune
24 Nov 2025
Amorphical Announces First Patient Enrolled in Phase 2 Clinical Trial of Nano-Amorphous Mineral-Based Therapy in ...
The Eagle-Tribune
24 Nov 2025
Edit
Amorphical Announces First Patient Enrolled in Phase 2 Clinical Trial of Nano-Amorphous Mineral-Based Therapy in Stage IV Pancreatic Cancer Patients
PR Newswire 24 Nov 2025
Amorphical's ... "Our goal is to investigate whether Amorphical's nano-amorphous mineral-based therapy can extend patient survival and improve quality of life for those with this aggressive disease."
- 1